Skip to content

Impact of Immunosuppression on antimicrobial sensitivity pattern, and outcome of Catheter-Associated Urinary Tract Infections (CAUTI) in ICU Patients: An Observational Study

Impact of Immunosuppression on antimicrobial sensitivity pattern, and outcome of Catheter-Associated Urinary Tract Infections in ICU Patients: An Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085527
Enrollment
60
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients (18 years and above) admitted to the ICU. 2. Hospitalization for more than 48 hours. 3. Patient with a urinary catheter in place for more than 48 hours. 4. Patients with confirmed CAUTI.

Exclusion criteria

Exclusion criteria: 1.Patients with pre-existing UTIs at the time of ICU admission. 2.Patients with incomplete medical records or follow-up data. 3.Patients who decline participation.

Design outcomes

Primary

MeasureTime frame
Antimicrobial drug susceptibility pattern of identified bacterial flora responsible for CAUTI in immunocompromised versus non-immunocompromised ICU patients.Timepoint: At confirmation of CAUTI

Secondary

MeasureTime frame
1. Adherence to CAUTI bundle & adequate antibiotic treatment for CAUTI in immunocompromised versus non-immunocompromised ICU patients.Timepoint: For 7 days post Inclusion;2. Response to antibiotic treatment (urine culture negative at one week) for CAUTI in immunocompromised versus non-immunocompromised ICU patients.Timepoint: For 7days Post Inclusion;3. Underlying risk factors contributing to CAUTI in immunocompromised versus non-immunocompromised ICU patients.Timepoint: At the time of Inclusion

Countries

India

Contacts

Public ContactDr Gaurav Jain

All India Institute of Medical Sciences, Rishikesh

gauravhld@gmail.com8808631209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026